Literature DB >> 2872102

Protection against intranasal infection of mice with Bordetella pertussis.

A Robinson, L A Ashworth, A Baskerville, L I Irons.   

Abstract

Mice have been infected by intranasal instillation of Bordetella pertussis and the infection monitored by determining numbers of bacteria isolated from the lungs. Outer membrane proteins, filamentous hemagglutinin, toxoided-lymphocytosis promoting factor and agglutinogens (fimbriae) actively protect mice against intranasal infection and antibodies of the antigens neutralize infectivity. The neutralization of infection by agglutinins is serospecific. In general, antigens that actively protect mice against intracerebral infections also protect against intranasal infections but some antigens, such as filamentous hemagglutinin and agglutinogens, protect only against intranasal infections. The intranasal protective potency of antigens can be enhanced by including low levels of active lymphocytosis promoting factor in the preparations. The relevance of the intranasal test to the potency testing of pertussis vaccines is discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2872102

Source DB:  PubMed          Journal:  Dev Biol Stand        ISSN: 0301-5149


  13 in total

1.  Differential regulation of Bvg-activated virulence factors plays a role in Bordetella pertussis pathogenicity.

Authors:  S M Kinnear; R R Marques; N H Carbonetti
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

2.  Role of Bordetella pertussis virulence factors in adherence to epithelial cell lines derived from the human respiratory tract.

Authors:  B M van den Berg; H Beekhuizen; R J Willems; F R Mooi; R van Furth
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

3.  Insertion element IS987 from Mycobacterium bovis BCG is located in a hot-spot integration region for insertion elements in Mycobacterium tuberculosis complex strains.

Authors:  P W Hermans; D van Soolingen; E M Bik; P E de Haas; J W Dale; J D van Embden
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

4.  Characterization of the fim2 and fim3 fimbrial subunit genes of Bordetella bronchiseptica: roles of Fim2 and Fim3 fimbriae and flagella in adhesion.

Authors:  P H Savelkoul; D P de Kerf; R J Willems; F R Mooi; B A van der Zeijst; W Gaastra
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

5.  Activation of complement receptor 3 on human monocytes by cross-linking of very-late antigen-5 is mediated via protein tyrosine kinases.

Authors:  B M van den Berg; R van Furth; W L Hazenbos
Journal:  Immunology       Date:  1999-10       Impact factor: 7.397

6.  Genomic fluidity of Bordetella pertussis assessed by a new method for chromosomal mapping.

Authors:  S Stibitz; M S Yang
Journal:  J Bacteriol       Date:  1997-09       Impact factor: 3.490

7.  Pertussis toxin analog with reduced enzymatic and biological activities is a protective immunogen.

Authors:  A Kimura; K T Mountzouros; P A Schad; W Cieplak; J L Cowell
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

8.  Mucosal immunization with filamentous hemagglutinin protects against Bordetella pertussis respiratory infection.

Authors:  R D Shahin; D F Amsbaugh; M F Leef
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

9.  Insertion element IS1081-associated restriction fragment length polymorphisms in Mycobacterium tuberculosis complex species: a reliable tool for recognizing Mycobacterium bovis BCG.

Authors:  D van Soolingen; P W Hermans; P E de Haas; J D van Embden
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

10.  Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity.

Authors:  K Redhead; J Watkins; A Barnard; K H Mills
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.